Copyright Reports & Markets. All rights reserved.

Global Type 1 Diabetes (T1D) Sales Market Report 2021

Request for Sample of this report
Buy now

1 Type 1 Diabetes (T1D) Market Overview

  • 1.1 Type 1 Diabetes (T1D) Product Scope
  • 1.2 Type 1 Diabetes (T1D) Segment by Type
    • 1.2.1 Global Type 1 Diabetes (T1D) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Rapid Acting Insulin Analogs
    • 1.2.3 Long Acting Insulin Analogs
    • 1.2.4 Premix Insulin Analogs
  • 1.3 Type 1 Diabetes (T1D) Segment by Application
    • 1.3.1 Global Type 1 Diabetes (T1D) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Children
    • 1.3.3 Adults
  • 1.4 Type 1 Diabetes (T1D) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Type 1 Diabetes (T1D) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Type 1 Diabetes (T1D) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Type 1 Diabetes (T1D) Price Trends (2016-2027)

2 Type 1 Diabetes (T1D) Estimates and Forecasts by Region

  • 2.1 Global Type 1 Diabetes (T1D) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Type 1 Diabetes (T1D) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Type 1 Diabetes (T1D) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Type 1 Diabetes (T1D) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Type 1 Diabetes (T1D) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.3 China Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)
    • 2.4.6 India Type 1 Diabetes (T1D) Estimates and Projections (2016-2027)

3 Global Type 1 Diabetes (T1D) Competition Landscape by Players

  • 3.1 Global Top Type 1 Diabetes (T1D) Players by Sales (2016-2021)
  • 3.2 Global Top Type 1 Diabetes (T1D) Players by Revenue (2016-2021)
  • 3.3 Global Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Type 1 Diabetes (T1D) as of 2020)
  • 3.4 Global Type 1 Diabetes (T1D) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Type 1 Diabetes (T1D) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Type 1 Diabetes (T1D) Market Size by Type

  • 4.1 Global Type 1 Diabetes (T1D) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Type 1 Diabetes (T1D) Price by Type (2016-2021)
  • 4.2 Global Type 1 Diabetes (T1D) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Type 1 Diabetes (T1D) Price Forecast by Type (2022-2027)

5 Global Type 1 Diabetes (T1D) Market Size by Application

  • 5.1 Global Type 1 Diabetes (T1D) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Type 1 Diabetes (T1D) Price by Application (2016-2021)
  • 5.2 Global Type 1 Diabetes (T1D) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Type 1 Diabetes (T1D) Price Forecast by Application (2022-2027)

6 North America Type 1 Diabetes (T1D) Market Facts & Figures

  • 6.1 North America Type 1 Diabetes (T1D) Sales by Company
    • 6.1.1 North America Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 6.1.2 North America Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 6.2 North America Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 6.2.1 North America Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 6.3.1 North America Type 1 Diabetes (T1D) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Type 1 Diabetes (T1D) Sales Breakdown by Application (2022-2027)

7 Europe Type 1 Diabetes (T1D) Market Facts & Figures

  • 7.1 Europe Type 1 Diabetes (T1D) Sales by Company
    • 7.1.1 Europe Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 7.1.2 Europe Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 7.2 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 7.2.1 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Type 1 Diabetes (T1D) Market Facts & Figures

  • 8.1 China Type 1 Diabetes (T1D) Sales by Company
    • 8.1.1 China Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 8.1.2 China Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 8.2 China Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 8.2.1 China Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 8.3 China Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 8.3.1 China 154 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Type 1 Diabetes (T1D) Market Facts & Figures

  • 9.1 Japan Type 1 Diabetes (T1D) Sales by Company
    • 9.1.1 Japan Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 9.1.2 Japan Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 9.2 Japan Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 9.2.1 Japan Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Type 1 Diabetes (T1D) Market Facts & Figures

  • 10.1 Southeast Asia Type 1 Diabetes (T1D) Sales by Company
    • 10.1.1 Southeast Asia Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Type 1 Diabetes (T1D) Market Facts & Figures

  • 11.1 India Type 1 Diabetes (T1D) Sales by Company
    • 11.1.1 India Type 1 Diabetes (T1D) Sales by Company (2016-2021)
    • 11.1.2 India Type 1 Diabetes (T1D) Revenue by Company (2016-2021)
  • 11.2 India Type 1 Diabetes (T1D) Sales Breakdown by Type
    • 11.2.1 India Type 1 Diabetes (T1D) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Type 1 Diabetes (T1D) Sales Breakdown by Type (2022-2027)
  • 11.3 India Type 1 Diabetes (T1D) Sales Breakdown by Application
    • 11.3.1 India Type 1 Diabetes (T1D) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Type 1 Diabetes (T1D) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Type 1 Diabetes (T1D) Business

  • 12.1 Novo Nordisk
    • 12.1.1 Novo Nordisk Corporation Information
    • 12.1.2 Novo Nordisk Business Overview
    • 12.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Novo Nordisk Type 1 Diabetes (T1D) Products Offered
    • 12.1.5 Novo Nordisk Recent Development
  • 12.2 Sanofi
    • 12.2.1 Sanofi Corporation Information
    • 12.2.2 Sanofi Business Overview
    • 12.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Sanofi Type 1 Diabetes (T1D) Products Offered
    • 12.2.5 Sanofi Recent Development
  • 12.3 Eli Lilly
    • 12.3.1 Eli Lilly Corporation Information
    • 12.3.2 Eli Lilly Business Overview
    • 12.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Eli Lilly Type 1 Diabetes (T1D) Products Offered
    • 12.3.5 Eli Lilly Recent Development
  • 12.4 Merck
    • 12.4.1 Merck Corporation Information
    • 12.4.2 Merck Business Overview
    • 12.4.3 Merck Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Merck Type 1 Diabetes (T1D) Products Offered
    • 12.4.5 Merck Recent Development
  • 12.5 Boehringer Ingelheim
    • 12.5.1 Boehringer Ingelheim Corporation Information
    • 12.5.2 Boehringer Ingelheim Business Overview
    • 12.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Products Offered
    • 12.5.5 Boehringer Ingelheim Recent Development
  • 12.6 Samsung Bioepis
    • 12.6.1 Samsung Bioepis Corporation Information
    • 12.6.2 Samsung Bioepis Business Overview
    • 12.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Products Offered
    • 12.6.5 Samsung Bioepis Recent Development
  • 12.7 Biocon
    • 12.7.1 Biocon Corporation Information
    • 12.7.2 Biocon Business Overview
    • 12.7.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Biocon Type 1 Diabetes (T1D) Products Offered
    • 12.7.5 Biocon Recent Development
  • 12.8 Astellas
    • 12.8.1 Astellas Corporation Information
    • 12.8.2 Astellas Business Overview
    • 12.8.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Astellas Type 1 Diabetes (T1D) Products Offered
    • 12.8.5 Astellas Recent Development
  • 12.9 Janssen
    • 12.9.1 Janssen Corporation Information
    • 12.9.2 Janssen Business Overview
    • 12.9.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Janssen Type 1 Diabetes (T1D) Products Offered
    • 12.9.5 Janssen Recent Development
  • 12.10 Bristol-Myers Squibb
    • 12.10.1 Bristol-Myers Squibb Corporation Information
    • 12.10.2 Bristol-Myers Squibb Business Overview
    • 12.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Products Offered
    • 12.10.5 Bristol-Myers Squibb Recent Development
  • 12.11 Lexicon
    • 12.11.1 Lexicon Corporation Information
    • 12.11.2 Lexicon Business Overview
    • 12.11.3 Lexicon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Lexicon Type 1 Diabetes (T1D) Products Offered
    • 12.11.5 Lexicon Recent Development
  • 12.12 Sanofi
    • 12.12.1 Sanofi Corporation Information
    • 12.12.2 Sanofi Business Overview
    • 12.12.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Sanofi Type 1 Diabetes (T1D) Products Offered
    • 12.12.5 Sanofi Recent Development

13 Type 1 Diabetes (T1D) Manufacturing Cost Analysis

  • 13.1 Type 1 Diabetes (T1D) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Type 1 Diabetes (T1D)
  • 13.4 Type 1 Diabetes (T1D) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Type 1 Diabetes (T1D) Distributors List
  • 14.3 Type 1 Diabetes (T1D) Customers

15 Market Dynamics

  • 15.1 Type 1 Diabetes (T1D) Market Trends
  • 15.2 Type 1 Diabetes (T1D) Drivers
  • 15.3 Type 1 Diabetes (T1D) Market Challenges
  • 15.4 Type 1 Diabetes (T1D) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Type 1 Diabetes (T1D) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes (T1D) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Rapid Acting Insulin Analogs
    Long Acting Insulin Analogs
    Premix Insulin Analogs

    Segment by Application
    Children
    Adults

    The Type 1 Diabetes (T1D) market is analysed and market size information is provided by regions (countries). Segment by Application, the Type 1 Diabetes (T1D) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Novo Nordisk
    Sanofi
    Eli Lilly
    Merck
    Boehringer Ingelheim
    Samsung Bioepis
    Biocon
    Astellas
    Janssen
    Bristol-Myers Squibb
    Lexicon
    Sanofi

    Buy now